Collegium Pharmaceutical Inc (NASDAQ:COLL)

20.09
Delayed Data
As of Aug 05
 +1.58 / +8.54%
Today’s Change
14.04
Today|||52-Week Range
25.22
+7.55%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Operating ActivitiesNet Income / Starting Line-16.5M9.1M-9.7M-4.7M
 
 
 
 
 
Depreciation32.6M15.8M3.9M3.9M
 
 
 
 
 
Total Other Cash Flow9.6M5.8M4.4M4.3M
 
 
 
 
 
Funds From Operations25.6M30.7M-1.5M3.4M
 
 
 
 
 
Funds From/For Other Operating Expenses-16.2M-11.6M7.1M-11.2M
 
 
 
 
 
Net Cash Flow - Operating Activities41.8M42.3M-8.6M14.6M
 
 
 
 
 
 
InvestingCapital Expenditures-2.7M-1.8M-3.3M-875.0K
 
 
 
 
 
Net Cash Flow Investing-2.7M-1.8M-3.3M-875.0K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings1.0K0.000.000.00
 
 
Long Term Debt Reduction-33.8M98.3M0.000.00
 
 
 
Net Proceeds Stock Sale789.0K168.0K657.0K86.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing114.0K132.1M488.0K35.0K
 
 
 
 
 
Net Cash Flow - Financing-33.1M-33.7M169.0K51.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash6.0M6.8M-11.7M13.8M